【ChiCTR2600130030】Cryotherapy Versus Lidocaine Spray for the Management of Chemotherapy-Induced Oral Mucositis: A Randomized Controlled Trial
ChiCTR2600130030
尚未开始
/
/
/
2026-08-13
/
/
cancer
Cryotherapy Versus Lidocaine Spray for the Management of Chemotherapy-Induced Oral Mucositis: A Randomized Controlled Trial
Cryotherapy Versus Lidocaine Spray for the Management of Chemotherapy-Induced Oral Mucositis: A Randomized Controlled Trial
41001
Primary: Compare oral cryotherapy and topical lidocaine spray in reducing oral mucositis severity. Secondary: Compare oral pain intensity, time to recovery, patient tolerance, and adverse events.
随机平行对照
其它
The random allocation sequence was generated by an independent researcher who was not involved in participant recruitment, intervention delivery, or outcome assessment. A computer-generated random number sequence with a 1:1 allocation ratio was used to assign participants to either the oral cryotherapy group or the topical lidocaine spray group.
None
self-raised
/
30
/
2026-10-20
2026-12-15
/
Adults ≥18 years; diagnosed with cancer; receiving chemotherapy; developed chemotherapy-induced oral mucositis; able to provide informed consent. Adults ≥18 years; diagnosed with cancer; receiving chemotherapy; developed chemotherapy-induced oral mucositis; able to provide informed consent.；
请登录查看Mucositis from causes other than chemotherapy; concurrent head and neck radiotherapy; allergy to lidocaine; contraindication to cryotherapy; severe cognitive impairment; refusal to participate.；
请登录查看College of Nursing, University of Baghdad
/
College of Nursing, University of Baghdad的其他临床试验
- Effect of Aloe Vera- Peppermint compound gel in prevention bed injuries among ICU bedridden patients
- Cryotherapy Versus Lidocaine Spray for the Management of Chemotherapy-Induced Oral Mucositis: A Randomized Controlled Trial
- Protective Dressing on Reducing Nasal Injury in Preterm Infants treating with CPAP
- Effect of a Health Education Program on Lung Cancer Screening among College Students Who Smoke
- Effect of Buteyko Breathing Exercises and Virtual Reality on Anxiety and sleep Quality in Patients poste Coronary Artery Bypass Grafting: A Randomized Controlled Trial
- Effect of Combined Stress Ball and Lavender Oil on Pain and Anxiety during Arteriovenous Cannulation in Hemodialysis Patients: A Randomized Controlled Trial
College of Nursing, University of Baghdad的其他临床试验
- Effect of Aloe Vera- Peppermint compound gel in prevention bed injuries among ICU bedridden patients
- Cryotherapy Versus Lidocaine Spray for the Management of Chemotherapy-Induced Oral Mucositis: A Randomized Controlled Trial
- Protective Dressing on Reducing Nasal Injury in Preterm Infants treating with CPAP
- Effect of a Health Education Program on Lung Cancer Screening among College Students Who Smoke
- Effect of Buteyko Breathing Exercises and Virtual Reality on Anxiety and sleep Quality in Patients poste Coronary Artery Bypass Grafting: A Randomized Controlled Trial
- Effect of Combined Stress Ball and Lavender Oil on Pain and Anxiety during Arteriovenous Cannulation in Hemodialysis Patients: A Randomized Controlled Trial
- Effect of Listening to Quran versus Verbal Communication on Respiratory Suctioning-Induced Pain and Agitation among Intubated Patients: A Randomized Controlled Trail
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04